Search - tctmd.com

Displaying 41 - 60 of 126

Sort: Relevancy | Date

Presentation THT 2025

Magenta Elevate™ pLVAD: Breaking the Flow/Fr Size Ceiling of Mechanical Circulatory Support

Presenter: Ajay Kirtane

February 11, 2025

Presentation THT 2025

From Surgical to Interventional: ECMO Cannulation Outside the OR

Presenter: Amirali Masoumi

February 11, 2025

Presentation THT 2025

Impella 5.5: A GameChanger for Cardiogenic Shock

Presenter: Jerome Crowley

February 11, 2025

Presentation THT 2025

Differential Outcome of Hypotension vs. Hypoperfusion in SCAI Stage B Cardiogenic Shock: Insights From Houston Methodist Advanced Heart Failure Registry (HM-AHFR)

Presenter: Sumitabh Singh

February 11, 2025

Presentation THT 2025

New Technologies for Pulsatile ECMO

Presenter: Nader Moazami

February 11, 2025

Presentation THT 2025

Supira Expandable Cage Temporary Transvalvular Percutaneous Support Device

Presenter: Gagan Singh

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study

Presenter: Kevin Croce

February 11, 2025

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

The RECOVER IV Study Overview

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Pulmonary Artery Catheter in Shock (PACCS)

Presenter: Shashank Shekhar Sinha

March 05, 2024

Presentation THT 2024

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Presenter: Dirk Westermann

March 05, 2024

Presentation THT 2024

DoReMe: Are Inotropes Helpful or Harmful?

Presenter: Benjamin Hibbert

March 05, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

Presentation THT 2024

Deep Phenotyping in Cardiogenic Shock

Presenter: Song Li

March 05, 2024

Presentation THT 2024

Risk Stratification: Thinking Beyond SCAI Staging

Presenter: David A. Baran

March 05, 2024

Presentation THT 2024

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Presenter: Mariell Jessup

March 05, 2024

Advertisement

Magenta Elevate™ pLVAD: Breaking the Flow/Fr Size Ceiling of Mechanical Circulatory Support

From Surgical to Interventional: ECMO Cannulation Outside the OR

Impella 5.5: A GameChanger for Cardiogenic Shock

Differential Outcome of Hypotension vs. Hypoperfusion in SCAI Stage B Cardiogenic Shock: Insights From Houston Methodist Advanced Heart Failure Registry (HM-AHFR)

New Technologies for Pulsatile ECMO

Supira Expandable Cage Temporary Transvalvular Percutaneous Support Device

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

DPP3-Based Biotherapy in Cardiogenic Shock

Ivabridine in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

The RECOVER IV Study Overview

Pulmonary Artery Catheter in Shock (PACCS)

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

DoReMe: Are Inotropes Helpful or Harmful?

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Deep Phenotyping in Cardiogenic Shock

Risk Stratification: Thinking Beyond SCAI Staging

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content